EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Plant-Based Diets as a Therapeutic Strategy for Obesity: Modulation of Adipogenesis, Inflammation, Energy Homeostasis, and Metabolic Dysfunction

Hanyue Shi iD, Jared Sieusahai, Marina Kamel iD, Clarence Wong iD, Andrew Mason, Zobair Younossi, Christophe Corpechot iD, Eduardo Grunvald iD, Olexandr Troshyn, Andrea Galli iD, Sahar Iqbal iD, Jasdeep Saluja und 2 weitere

Nutrients · 29.10.2026 · 18 (21) · 3592

DOI: 10.3390/nu18213592 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 29.10.2026. Verfasst von Hanyue Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Preventive Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2T4, Canada. Hauptthemen laut MEDLINE: Obesity, Energy Metabolism, Adipogenesis. Die Arbeit nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Obesity is a chronic, relapsing disease driven by dysregulated energy balance, appetite, adipose tissue function, and metabolic homeostasis. Dietary modification remains central to long-term management. Plant-based diets (PBDs), particularly those emphasizing minimally processed plant foods, are associated with lower adiposity and improved cardiometabolic health. This review synthesizes human evidence on weight-loss efficacy and mechanisms linking PBDs to obesity and adiposity-related outcomes.

Methods

Following PRISMA-ScR guidance, PubMed and Scopus were searched for English-language adult human studies published from January 2010 to August 2026. Of 1439 records identified and 1297 screened after deduplication, 168 studies met the inclusion criteria and were synthesized descriptively.

Results

Human studies support beneficial effects of PBDs on spontaneous energy intake, insulin sensitivity, visceral and ectopic lipid accumulation, and circulating lipid profiles. Clinical trials indicate that PBDs can support weight loss, although superiority over other dietary approaches needs further exploration. Proposed mechanisms include lower dietary energy density and greater satiation, improved lipid partitioning, increased postprandial energy expenditure, reduced oxidative and inflammatory stress, and altered gut microbial metabolism and enteroendocrine signaling. Evidence also suggests diet-responsive epigenetic changes. Direct human evidence for effects on central appetite circuitry, brown or beige adipose tissue, and weight-independent molecular pathways remains limited.

Conclusions

High-quality PBDs represent a biologically coherent and scalable strategy for obesity management, with evidence suggesting benefits for energy intake and selected aspects of cardiometabolic health, including energy intake, insulin resistance, lipid metabolism, systemic inflammation, and gut-derived signaling. These effects position high-quality PBDs as a promising strategy for reducing the risk of obesity-related complications, including type 2 diabetes, cardiovascular disease, MASLD, and selected cancers. Further well-designed controlled trials will help clarify the independent contributions of dietary composition and the beneficial effects mediated through reduced energy intake and sustained weight loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityEnergy MetabolismAdipogenesisHumansDiet, Plant-BasedInflammationHomeostasisWeight LossInsulin ResistanceMetabolic Diseases

Stichwörter der Autor:innen

adipose tissuecardiometabolic healthchronic inflammationdietary fibregut microbiotainsulin resistancelipid metabolismobesityplant-based dietshort-chain fatty acids

Autor:innen und Institutionen

  • Division of Preventive Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2T4, Canada.
  • Department of Medicine, University of Galway, H91 TK33 Galway, Ireland.
  • Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada.
  • Global NASH/MASH Council Center for Outcomes Research in Liver Disease, Washington, DC 20037, USA.
  • Global Center for Liver Outcomes & Policy Research, School of Medicine, Georgetown University, Washington, DC 20057, USA.
  • Hôpital Saint-Antoine, Sorbonne University, 75012 Paris, France.

ORCID-Profile: Hanyue Shi, Marina Kamel, Clarence Wong, Christophe Corpechot, Eduardo Grunvald, Andrea Galli, Sahar Iqbal, Sebastian Straube, Ellina Lytvyak

Zitieren

APA

Shi, H., Sieusahai, J., Kamel, M., Wong, C., Mason, A., Younossi, Z., Corpechot, C., Grunvald, E., Troshyn, O., Galli, A., Iqbal, S., Saluja, J., Straube, S., & Lytvyak, E. (2026). Plant-Based Diets as a Therapeutic Strategy for Obesity: Modulation of Adipogenesis, Inflammation, Energy Homeostasis, and Metabolic Dysfunction. Nutrients, 18(21), 3592. https://doi.org/10.3390/nu18213592

Vancouver

Shi H, Sieusahai J, Kamel M, Wong C, Mason A, Younossi Z, et al. Plant-Based Diets as a Therapeutic Strategy for Obesity: Modulation of Adipogenesis, Inflammation, Energy Homeostasis, and Metabolic Dysfunction. Nutrients. 2026;18(21):3592. doi:10.3390/nu18213592

BibTeX
@article{Shi2026,
  author = {Shi, Hanyue and Sieusahai, Jared and Kamel, Marina and Wong, Clarence and Mason, Andrew and Younossi, Zobair and Corpechot, Christophe and Grunvald, Eduardo and Troshyn, Olexandr and Galli, Andrea and Iqbal, Sahar and Saluja, Jasdeep and Straube, Sebastian and Lytvyak, Ellina},
  title = {Plant-Based Diets as a Therapeutic Strategy for Obesity: Modulation of Adipogenesis, Inflammation, Energy Homeostasis, and Metabolic Dysfunction},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3592},
  doi = {10.3390/nu18213592}
}
Kostenlos starten →